{"id":"epor","name":"Erythropoietin receptor (EPOR)","symbol":"EPOR","route":"/targets/epor/","asOf":"2026-09-04","xrefs":[{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:3416","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000187266","uniprot":"https://www.uniprot.org/uniprotkb/P19235/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/P19235","chembl":"https://www.ebi.ac.uk/chembl/explore/target/CHEMBL1817","open-targets":"https://platform.opentargets.org/target/ENSG00000187266","civic":"https://civicdb.org/genes/2057/summary","oncokb":"https://www.oncokb.org/gene/EPOR","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=EPOR","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=EPOR","depmap":"https://depmap.org/portal/gene/EPOR?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000187266-EPOR","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/2057","omim":"https://www.omim.org/entry/133171"}],"products":[{"id":"epoetin-theta","name":"Epoetin theta","status":"approved","modality":"Recombinant erythropoietin (erythropoiesis-stimulating agent)","route":"/drugs/epoetin-theta/"}],"trials":[{"id":"xm01-22","name":"XM01-22","nct":"ISRCTN08063129","phase":"3","status":"positive"}],"pathways":[],"companies":["teva"],"keyPapers":["paper-xm01-22-tjulandin-arch-drug-inf-2011"],"hotspots":[],"openQuestions":[],"assays":[],"resistance":[],"licence":"CC BY-NC 4.0, attribution to OnCo (https://onco.cc); commercial use needs a licence"}